Ultivue

Ultivue is a developer of high-resolution biological in-situ imaging technology based on chemical reagents, aiming to use DNA nanostructures to impact cancer research. The reagents produced by Ultivue enable researchers to obtain microscopic images with unprecedented resolution, which aids in understanding biology and medicine. Ultivue's products are designed for fluorescence microscopy-based research and will ultimately be used for clinical diagnostics, providing researchers and scientists with multiplex biomarker detection methods for tissue phenotyping and digital pathology. Our proprietary InSituPlex® technology allows for advanced exploration and interrogation of tissue samples for precision medicine research. Our highly customizable solutions and scientific consulting approach enhance and accelerate biomarker discovery and drug development programs.